Drug News April 14, 2026
Updated: FDA asks for data on Lilly’s Foundayo to assess heart, liver risks
This article from Endpoints News covers: Updated: FDA asks for data on Lilly’s Foundayo to assess heart, liver risks.
Source: Endpoints News • Editorial summary by GLP-1 Price Guide
What This Means for You
This article from Endpoints News covers: Updated: FDA asks for data on Lilly’s Foundayo to assess heart, liver risks.
This article from Endpoints News covers: Updated: FDA asks for data on Lilly’s Foundayo to assess heart, liver risks.
Source: Endpoints News
Original source
Read the full article at Endpoints News